Skip to main content
Premium Trial:

Request an Annual Quote

AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies

NEW YORK ─ Riken Genesis, Amoy Diagnostics, and Precision Medicine Asia on Wednesday announced that the Japanese Ministry of Health, Labour, and Welfare has approved the AmoyDx Pan Lung Cancer PCR Panel for production and marketing in Japan.

The real-time PCR panel, manufactured by Xiamen, China-based AmoyDx, is an IVD reagent developed as a CDx for multiple anti-cancer agents.

The test, also called the AmoyDx PLC Panel, has received approval for four driver genes — EGFR, ALK, ROS1, and BRAF — for nine associated targeted therapies in non-small cell lung cancer. It is expected to be an important clinical diagnostic in guiding treatment for advanced NSCLC patients, the firms said.

"The approval of the AmoyDx PLC Panel marks the first time that Japanese patients will have direct access to a locally administered multi-gene PCR CDx with a very short turnaround time from sample to diagnosis," Li-Mou Zheng, founder and CEO of AmoyDx, said in a statement.

The panel can simultaneously evaluate the presence of 11 driver genes (EGFR/ ALK/ ROS1/ KRAS/ BRAF/ HER2/ RET/ MET/ NTRK1/ NTRK2/ NTRK3 genes) when all genes on the panel are approved as companion diagnostics, the firms said.

Riken Genesis and Precision Medicine Asia are based in Tokyo.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.